Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Formulation, By Type, By Therapy Area, By End User, By Region and Competition, 2020-2030F

Description

The Global Oral Drug Delivery Market, valued at USD 129.77 Billion in 2024, is projected to experience a CAGR of 7.80% to reach USD 203.65 Billion by 2030. The Global Oral Drug Delivery Market encompasses the segment of the pharmaceutical industry dedicated to developing, manufacturing, and commercializing therapeutic agents administered via the oral route. This method is highly favored due to its inherent patient convenience, ease of administration, and potential for improved compliance compared to other delivery methods. Key drivers propelling this market include the increasing global prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer, which necessitate long-term medication regimens.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 129.77 Billion
Market Size 2030	USD 203.65 Billion
CAGR 2025-2030	7.8%
Fastest Growing Segment	Tablets
Largest Market	North America

Key Market Drivers

Technological advancements in drug delivery systems and expanded investment in pharmaceutical research and development exert considerable influence on the Global Oral Drug Delivery Market. Innovations in solubility enhancement, controlled release mechanisms, and targeted delivery are broadening the range of orally administered therapies, including complex molecules once limited to injectable routes. These developments improve drug stability, bioavailability, and therapeutic precision. For instance, according to Fierce Biotech, in April 2025, Roche acquired Carmot Therapeutics for $2.7 billion in late 2023, securing access to three GLP-1 receptor agonists with potential for treating obesity, including oral administration. Such strategic investments emphasize the industry's dedication to patient-friendly oral formulations.

Key Market Challenges

A significant challenge impeding market expansion for oral drug delivery is the stringent regulatory approval processes. These complex procedures inherently increase the time and financial investment required to bring new oral formulations to market. This extended development timeline and heightened cost create substantial barriers for pharmaceutical companies, particularly those developing innovative therapies, by prolonging the period before potential revenue generation.

Key Market Trends

The development of personalized oral therapies is a significant trend reshaping the Global Oral Drug Delivery Market by moving towards treatments tailored to individual patient profiles. This approach leverages advancements in diagnostics and genomics to customize drug selection, dosage, and formulation, enhancing therapeutic efficacy and minimizing adverse effects. According to the Personalized Medicine Coalition (PMC), in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities. These approvals underscore a growing industry commitment to individualized treatment pathways.

Key Market Players

Novartis AG
Biocon Ltd.
NovoNordisk A/S
F.Hoffmann-La Roche Ltd.
Bayer AG
Emishphere Technologies Inc.
Enteris Biopharma Inc.
Merrion Pharmaceuticals Plc.
Amgen Inc.
Pfizer Inc.

Report Scope:

In this report, the Global Oral Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Drug Delivery Market, By Formulation:

Tablets
Capsules
Drops
Liquid or Syrup

Oral Drug Delivery Market, By Type:

Controlled Release
Orodispersible Tablets
Others

Oral Drug Delivery Market, By Therapy Area:

Oncology
Musculoskeletal
Immunology
Gastrointestinal
Respiratory
Cardiovascular
Others

Oral Drug Delivery Market, By End User:

Hospitals
Ambulatory Surgical Centres
Diagnostic Centres
Clinics
Others

Oral Drug Delivery Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Drug Delivery Market.

Available Customizations:

Global Oral Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Drug Delivery Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
- 5.2.2. By Type (Controlled Release, Orodispersible Tablets, Others)
- 5.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)
- 5.2.4. By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Oral Drug Delivery Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Formulation
- 6.2.2. By Type
- 6.2.3. By Therapy Area
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Oral Drug Delivery Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Formulation
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By Therapy Area
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Oral Drug Delivery Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Formulation
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By Therapy Area
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Oral Drug Delivery Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Formulation
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By Therapy Area
    - 6.3.3.2.4. By End User

7. Europe Oral Drug Delivery Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Formulation
- 7.2.2. By Type
- 7.2.3. By Therapy Area
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Oral Drug Delivery Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Formulation
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Therapy Area
    - 7.3.1.2.4. By End User
- 7.3.2. France Oral Drug Delivery Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Formulation
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Therapy Area
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Oral Drug Delivery Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Formulation
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Therapy Area
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Oral Drug Delivery Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Formulation
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By Therapy Area
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Oral Drug Delivery Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Formulation
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By Therapy Area
    - 7.3.5.2.4. By End User

8. Asia Pacific Oral Drug Delivery Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Formulation
- 8.2.2. By Type
- 8.2.3. By Therapy Area
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Oral Drug Delivery Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Formulation
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Therapy Area
    - 8.3.1.2.4. By End User
- 8.3.2. India Oral Drug Delivery Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Formulation
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Therapy Area
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Oral Drug Delivery Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Formulation
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Therapy Area
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Oral Drug Delivery Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Formulation
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By Therapy Area
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Oral Drug Delivery Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Formulation
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By Therapy Area
    - 8.3.5.2.4. By End User

9. Middle East & Africa Oral Drug Delivery Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Formulation
- 9.2.2. By Type
- 9.2.3. By Therapy Area
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Oral Drug Delivery Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Formulation
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Therapy Area
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Oral Drug Delivery Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Formulation
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Therapy Area
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Oral Drug Delivery Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Formulation
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Therapy Area
    - 9.3.3.2.4. By End User

10. South America Oral Drug Delivery Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Formulation
- 10.2.2. By Type
- 10.2.3. By Therapy Area
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Oral Drug Delivery Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Formulation
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By Therapy Area
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Oral Drug Delivery Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Formulation
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By Therapy Area
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Oral Drug Delivery Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Formulation
    - 10.3.3.2.2. By Type
    - 10.3.3.2.3. By Therapy Area
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Oral Drug Delivery Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Novartis AG
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Biocon Ltd.
15.3. NovoNordisk A/S
15.4. F.Hoffmann-La Roche Ltd.
15.5. Bayer AG
15.6. Emishphere Technologies Inc.
15.7. Enteris Biopharma Inc.
15.8. Merrion Pharmaceuticals Plc.
15.9. Amgen Inc.
15.10. Pfizer Inc.